Susquehanna International Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-513,700
| Closed | -$27M | – | 12147 |
|
|
2020
Q3 | $27M | Buy |
513,700
+498,800
| +3,348% | +$20.6M | 0.01% | 1241 |
|
|
2020
Q2 | $496K | Sell |
14,900
-14,600
| -49% | -$465K | ﹤0.01% | 7387 |
|
|
2020
Q1 | $802K | Buy |
29,500
+9,100
| +45% | +$253K | ﹤0.01% | 5891 |
|
|
2019
Q4 | $402K | Sell |
20,400
-52,600
| -72% | -$841K | ﹤0.01% | 7417 |
|
|
2019
Q3 | $946K | Buy |
73,000
+27,200
| +59% | +$328K | ﹤0.01% | 5803 |
|
|
2019
Q2 | $570K | Buy |
45,800
+3,600
| +9% | +$47.8K | ﹤0.01% | 7016 |
|
|
2019
Q1 | $613K | Buy |
42,200
+30,500
| +261% | +$390K | ﹤0.01% | 5906 |
|
|
2018
Q4 | $129K | Sell |
11,700
-12,000
| -51% | -$167K | ﹤0.01% | 8084 |
|
|
2018
Q3 | $623K | Sell |
23,700
-9,300
| -28% | -$251K | ﹤0.01% | 6133 |
|
|
2018
Q2 | $675K | Buy |
33,000
+18,100
| +121% | +$388K | ﹤0.01% | 6198 |
|
|
2018
Q1 | $270K | Sell |
14,900
-27,200
| -65% | -$453K | ﹤0.01% | 7796 |
|
|
2017
Q4 | $587K | Buy |
42,100
+11,100
| +36% | +$150K | ﹤0.01% | 6345 |
|
|
2017
Q3 | $574K | Buy |
31,000
+17,800
| +135% | +$298K | ﹤0.01% | 6285 |
|
|
2017
Q2 | $223K | Sell |
13,200
-5,100
| -28% | -$77.6K | ﹤0.01% | 8099 |
|
|
2017
Q1 | $244K | Buy |
+18,300
| New | +$287K | ﹤0.01% | 7711 |
|
|
2016
Q4 | – | Sell |
-22,900
| Closed | -$268K | – | 10405 |
|
|
2016
Q3 | $268K | Buy |
+22,900
| New | +$269K | ﹤0.01% | 7115 |
|
|
2016
Q1 | – | Sell |
-14,300
| Closed | -$212K | – | 9962 |
|
|
2015
Q4 | $212K | Sell |
14,300
-4,300
| -23% | -$72K | ﹤0.01% | 8327 |
|
|
2015
Q3 | $305K | Sell |
18,600
-27,900
| -60% | -$571K | ﹤0.01% | 8017 |
|
|
2015
Q2 | $1.06M | Sell |
46,500
-5,900
| -11% | -$118K | ﹤0.01% | 6100 |
|
|
2015
Q1 | $796K | Buy |
52,400
+25,800
| +97% | +$335K | ﹤0.01% | 6212 |
|
|
2014
Q4 | $320K | Sell |
26,600
-36,100
| -58% | -$413K | ﹤0.01% | 8024 |
|
|
2014
Q3 | $711K | Sell |
62,700
-376,800
| -86% | -$4.3M | ﹤0.01% | 6573 |
|
|
2014
Q2 | $5.31M | Buy |
439,500
+121,900
| +38% | +$1.44M | ﹤0.01% | 2979 |
|
|
2014
Q1 | $3.7M | Buy |
317,600
+194,300
| +158% | +$3.29M | ﹤0.01% | 3329 |
|
|
2013
Q4 | $2.18M | Sell |
123,300
-36,400
| -23% | -$612K | ﹤0.01% | 4127 |
|
|
2013
Q3 | $2.3M | Buy |
159,700
+58,000
| +57% | +$888K | ﹤0.01% | 3874 |
|
|
2013
Q2 | $1.53M | Buy |
+101,700
| New | +$1.34M | ﹤0.01% | 4331 |
|
Susquehanna International Group's MNTA Position: Q4 2020 in Review
Susquehanna International Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 255,154 shares — an estimated $13.4M sold.
Susquehanna International Group first reported a position in MNTA in Q3 2013 and held it in 17 quarters. The position peaked at $13.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Susquehanna International Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Susquehanna International Group sold 255,154 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $13.4M.
- Susquehanna International Group first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 17 quarters.
- Susquehanna International Group's Momenta Pharmaceuticals, Inc. position peaked at $13.4M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.